Literature DB >> 25744676

Role of extracellular damage-associated molecular pattern molecules (DAMPs) as mediators of persistent pain.

Jungo Kato1, Camilla I Svensson2.   

Abstract

Damage-associated molecular pattern molecules (DAMPs) are endogenous molecules that are constitutively expressed and released upon tissue damage, resulting in activation of the immune system. In the absence of injury or infection, DAMPs play important intracellular roles. However, once released subsequent to cell damage or cell stress, DAMPs promote activation of innate immune cells and recruitment and activation of antigen-presenting cells engaged in host defense and tissue repair. This process involves pattern recognition receptors, such as the Toll-like receptors (TLRs) and receptor for advanced glycation end products (RAGE). Several of the TLRs and RAGE have been implicated to play key roles not only in the detection of injury but also in pain signaling. Pain-like behavior is reduced in TLR2- and TLR4-deficient mice, and after injection of TLR2-, TLR4-, and RAGE antagonists in experimental models of nerve injury, arthritis, and bone cancer pain. This suggests that the pathological processes in these models are associated with release of endogenous TLR and RAGE ligands, and further that DAMPs play an important role in persistent pain. There is now a rapidly growing list of DAMPs in the literature and here we give an overview of DAMPs that have been associated with nociceptive signaling.
© 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DAMP; HMGB1; Heat-shock proteins; Pain; S100B; microRNA

Mesh:

Substances:

Year:  2015        PMID: 25744676     DOI: 10.1016/bs.pmbts.2014.11.014

Source DB:  PubMed          Journal:  Prog Mol Biol Transl Sci        ISSN: 1877-1173            Impact factor:   3.622


  26 in total

1.  Macrophage-derived HMGB1 as a Pain Mediator in the Early Stage of Acute Pancreatitis in Mice: Targeting RAGE and CXCL12/CXCR4 Axis.

Authors:  Yuhei Irie; Maho Tsubota; Hiroyasu Ishikura; Fumiko Sekiguchi; Yuka Terada; Toshifumi Tsujiuchi; Keyue Liu; Masahiro Nishibori; Atsufumi Kawabata
Journal:  J Neuroimmune Pharmacol       Date:  2017-07-28       Impact factor: 4.147

2.  A robust strategy for proteomic identification of biomarkers of invasive phenotype complexed with extracellular heat shock proteins.

Authors:  Steven G Griffiths; Alan Ezrin; Emily Jackson; Lisa Dewey; Alan A Doucette
Journal:  Cell Stress Chaperones       Date:  2019-10-24       Impact factor: 3.667

3.  Neuraxial TNF and IFN-beta co-modulate persistent allodynia in arthritic mice.

Authors:  Sarah A Woller; Cody Ocheltree; Stephanie Y Wong; Anthony Bui; Yuya Fujita; Gilson Gonçalves Dos Santos; Tony L Yaksh; Maripat Corr
Journal:  Brain Behav Immun       Date:  2018-11-19       Impact factor: 7.217

Review 4.  Red cell DAMPs and inflammation.

Authors:  Rafaela Mendonça; Angélica A A Silveira; Nicola Conran
Journal:  Inflamm Res       Date:  2016-06-01       Impact factor: 4.575

5.  Role of Thrombin in Soluble Thrombomodulin-Induced Suppression of Peripheral HMGB1-Mediated Allodynia in Mice.

Authors:  Ryuichi Tsujita; Maho Tsubota; Yusuke Hayashi; Haruka Saeki; Fumiko Sekiguchi; Atsufumi Kawabata
Journal:  J Neuroimmune Pharmacol       Date:  2017-12-01       Impact factor: 4.147

6.  A Dual Noradrenergic Mechanism for the Relief of Neuropathic Allodynia by the Antidepressant Drugs Duloxetine and Amitriptyline.

Authors:  Mélanie Kremer; Ipek Yalcin; Yannick Goumon; Xavier Wurtz; Laurent Nexon; Dorothée Daniel; Salim Megat; Rhian A Ceredig; Carl Ernst; Gustavo Turecki; Virginie Chavant; Jean-François Théroux; Adrien Lacaud; Lauriane-Elisabeth Joganah; Vincent Lelievre; Dominique Massotte; Pierre-Eric Lutz; Ralf Gilsbach; Eric Salvat; Michel Barrot
Journal:  J Neurosci       Date:  2018-09-24       Impact factor: 6.167

7.  Systemic TAK-242 prevents intrathecal LPS evoked hyperalgesia in male, but not female mice and prevents delayed allodynia following intraplantar formalin in both male and female mice: The role of TLR4 in the evolution of a persistent pain state.

Authors:  Sarah A Woller; Satheesh B Ravula; Fabio C Tucci; Graham Beaton; Maripat Corr; R Rivkah Isseroff; Athena M Soulika; Marianne Chigbrow; Kelly A Eddinger; Tony L Yaksh
Journal:  Brain Behav Immun       Date:  2016-04-01       Impact factor: 7.217

8.  Toll-like receptor 2 and 4 antagonism for the treatment of experimental autoimmune encephalomyelitis (EAE)-related pain.

Authors:  Andrew J Kwilasz; Suzanne M Green Fulgham; Julissa Chante Duran-Malle; Anouk E W Schrama; Eric H Mitten; Laurel S Todd; Hardik P Patel; Tracey A Larson; Madison A Clements; Kevin M Harris; Scott T Litwiler; Lewis O Harvey; Steven F Maier; Raymond A Chavez; Kenner C Rice; Anne-Marie Van Dam; Linda R Watkins
Journal:  Brain Behav Immun       Date:  2021-01-07       Impact factor: 7.217

9.  Heme Causes Pain in Sickle Mice via Toll-Like Receptor 4-Mediated Reactive Oxygen Species- and Endoplasmic Reticulum Stress-Induced Glial Activation.

Authors:  Jianxun Lei; Jinny Paul; Ying Wang; Mihir Gupta; Derek Vang; Susan Thompson; Ritu Jha; Julia Nguyen; Yessenia Valverde; Yann Lamarre; Michael K Jones; Kalpna Gupta
Journal:  Antioxid Redox Signal       Date:  2020-08-24       Impact factor: 8.401

10.  S100B has pleiotropic effects on vaso-occlusive manifestations in sickle cell disease.

Authors:  Xu Zhang; Binal N Shah; Wei Zhang; Santosh L Saraf; Mehdi Nouraie; Sergei Nekhai; Roberto F Machado; Mark T Gladwin; Victor R Gordeuk
Journal:  Am J Hematol       Date:  2020-01-01       Impact factor: 13.265

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.